revlimid.com 的前十大競爭對手

thalomid.com

important safety information warning: embryo-fetal toxicity and venous thromboembolism embryo-fetal toxicity if thalidomide is taken during pregnancy, it can cause severe birth defects or embryo-fetal death. thalidomide should never be used by females who are pregnant or who could become pregnant while taking the drug. even a single dose [1 capsule (regardless of strength)] taken by a pregnant woman during her pregnancy can cause severe birth defects because of this toxicity and in an effort to make the chance of embryo-fetal exposure to thalomid® (thalidomide) as negligible as possible, thalomid® (thalidomide) is approved for marketing only through a special restricted distribution program: thalomid rems® program, approved by the food and drug administration you can get the information about thalomid and the thalomid rems® program on the internet at www.celgeneriskmanagement.com or by calling the manufacturer's toll-free number 1-888-423-5436 venous thromboembolism the use of thalomid (thalidomide) in multiple myeloma results in an increased risk of venous thromboembolism, such as deep venous thrombosis and pulmonary embolism. this risk increases significantly when thalidomide is used in combination with standard chemotherapeutic agents including dexamethasone. in one controlled trial, the rate of venous thromboembolism was 22.5% in patients receiving thalidomide in combination with dexamethasone compared to 4.9% in patients receiving dexamethasone alone (p = 0.002). patients and physicians are advised to be observant for the signs and symptoms of thromboembolism. instruct patients to seek medical care if they develop symptoms such as shortness of breath, chest pain, or arm or leg swelling. consider thromboprophylaxis based on an assessment of individual patients’ underlying risk factors contraindications pregnancy: see boxed warnings. thalomid can cause fetal harm when administered to a pregnant female. thalomid is contraindicated in females who are pregnant. thal

fda.gov

FDA website policies

pomalyst.com

Explore POMALYST® (pomalidomide) treatment, a prescription medication used to treat adults. See Safety Info & Boxed WARNINGS on birth defects and blood clots.

velcade.com

Transforming cancer care through innovative medicines, pioneering research & patient-first approach. Explore our pipeline, therapies & commitment.

sancuso.com

Patch innovation in CINV Prevention. Sancuso® is the only FDA-approved transdermal patch for chemotherapy-induced nausea and vomiting

tarceva.com

breakthrough science. one moment, one day, one person at a time.

adcetris.com

Discover the efficacy and safety data from the ECHELON-2 clinical study of 400 patients, including side effects and other safety information.

canasa.com

learn about canasa (mesalamine) 1000 mg rectal suppository, a prescription medicine used to treat adults with mildly to moderately active ulcerative proctitis. view safety and full prescribing information, read disease information, and access patient resources.

invanz.com

for more than a century, merck has been inventing medicines and vaccines for many of the world's most challenging diseases. we have always been and always will be inventing, and we do it for the single greatest purpose: life.

gralise.com

phn treatment – gralise (gabapentin) tablets